Reagenta Pharmaceuticals Private Limited
About Reagenta Pharmaceuticals Private Limited
Data last updated:
Reagenta Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2019PTC331080. Its GSTIN is 23AAJCR8331B1ZO (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priyanka Mishra and Prabhakar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 101 Floor Grd Shanti Nagar Hutments Saltpan Road Antop Hill, Mumbai, Maharashtra, India – 400037.
As per the financials filed for FY 2025, the company reported a revenue of ₹69.17 Lakh, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹56,557 (net margin 0.8%) and EBITDA of ₹2.99 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No. 101 Floor Grd Shanti Nagar Hutments Saltpan Road Antop Hill, Mumbai, Maharashtra, India – 400037
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Reagenta Pharmaceuticals Private Limited
The main business activity of Reagenta Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Reagenta Pharmaceuticals Private Limited FY 2025 filings available
Reagenta Pharmaceuticals Private Limited reported revenue of ₹69.17 Lakh (up 56% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Reagenta Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over three years, including 56% growth in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Reagenta Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.99 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹56,557 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Reagenta Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Reagenta Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Reagenta Pharmaceuticals Private Limited
Reagenta Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Mishra | Director | 27 Sep 2019 | 7 Years 0 Months | Current |
| Prabhakar Mishra | Director | 27 Sep 2019 | 7 Years 0 Months | Current |
Peer Comparison of Reagenta Pharmaceuticals Private Limited
Reagenta Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axokare Lifesciences Private Limited | ₹69.27 Lakh (FY 2025) | •••• | •••• | •••• | Lucknow, Uttar Pradesh, India | |
| Nippon's Life Sciences Private Limited | ₹69.27 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Jaipur, Rajasthan, India |
| Asha Merchants Private Limited | ₹69.24 Lakh (FY 2025) | •••• | •••• | -48.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Leintz Pharmaceuticals and Chemicals Private Limited | ₹69.21 Lakh (FY 2018) | •••• | •••• | 24.0% | •••• | Bangalore, Karnataka, India |
| Chintalapati Holdings Private Limited | ₹69.21 Lakh (FY 2024) | •••• | •••• | -99.0% | •••• | Hyderabad, Telangana, India |
| Reagenta Pharmaceuticals Private Limited this company | ₹69.17 Lakh (FY 2025) | •••• | •••• | 56.0% | •••• | Mumbai, Maharashtra, India |
| Zhenpi Life Sciences Private Limited | ₹69.16 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Delhi, India |
| Aashirwad Chlorofins Private Limited | ₹69.15 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Panipat, Haryana, India |
| Bio Bit Pharmaceuticals Private Limited | ₹69.11 Lakh (FY 2025) | •••• | •••• | 52.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Prophex Healthcare Private Limited | ₹69.09 Lakh (FY 2022) | •••• | •••• | -22.0% | •••• | Chennai, Tamil Nadu, India |
| Chlora Aceso Pharmaceuticals Private Limited | ₹68.97 Lakh (FY 2024) | •••• | •••• | 73.0% | •••• | Prayagraj, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Reagenta Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Reagenta Pharmaceuticals Private Limited
Reagenta Pharmaceuticals Private Limited is audited by Arif Jain & Associates for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Arif Jain & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Reagenta Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Reagenta Pharmaceuticals Private Limited
Reagenta Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Reagenta Pharmaceuticals Private Limited
Reagenta Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Reagenta Pharmaceuticals. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (COMMS) | Filed by the company against Ragenta Pharmaceuticals | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Reagenta Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Reagenta Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Reagenta Pharmaceuticals Private Limited
Reagenta Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Prabhakar Mishra was appointed as Director on 27 Sep 2019.
Credit Ratings, Litigation & Regulatory Alerts for Reagenta Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Reagenta Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Reagenta Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Reagenta Pharmaceuticals Private Limited
Reagenta Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAJCR8331B1ZO | Madhya Pradesh | Active | 12 Sep 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Reagenta Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reagenta Pharmaceuticals Private Limited
Reagenta Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 September 2019 (7+ years old) and is registered under CIN U51909MH2019PTC331080.
Reagenta Pharmaceuticals reported revenue of ₹69.17 Lakh for FY 2025 (up 56% YoY).
Reagenta Pharmaceuticals has 2 current directors:
- Priyanka Mishra - Director
- Prabhakar Mishra - Director
Reagenta Pharmaceuticals reported a net profit of ₹56,557 (net margin 0.8%) and EBITDA of ₹2.99 Lakh (EBITDA margin 4.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Reagenta Pharmaceuticals is 12% over three years. In the latest year (FY 2025) revenue rose 56%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Reagenta Pharmaceuticals is 23AAJCR8331B1ZO, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Reagenta Pharmaceuticals is U51909MH2019PTC331080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reagenta Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Reagenta Pharmaceuticals was incorporated on 27 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Reagenta Pharmaceuticals by revenue are Axokare Lifesciences Private Limited, Nippon's Life Sciences Private Limited, Asha Merchants Private Limited, Leintz Pharmaceuticals and Chemicals Private Limited, Chintalapati Holdings Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Prabhakar Mishra was appointed as Director on 27 Sep 2019. Priyanka Mishra was appointed as Director on 27 Sep 2019.